Apheris funding news – Berlin-based Apheris has Secured €20.1 Million in Series A Round Funding

The round was led by European DeepTech investors OTB Ventures and eCAPITAL, with support from existing investors like Octopus Ventures and Heal Capital.

Robin Röhm, CEO of Apheris, expressed enthusiasm for the new partnerships: “I’m very excited to welcome OTB Ventures and eCAPITAL as new partners on our journey. Their deep understanding of the complexities of building a high-security, technically advanced product stood out. With their help, Apheris will unlock potential of AI & machine learning for the life science industry by solving its critical bottleneck: access to large and diverse data..”

Apheris, founded in 2019, uses federated computing technology to provide secure and private access to data across organizations. Their Compute Gateway allows AI model training without moving sensitive data, helping companies meet regulatory and commercial needs.

This approach has already attracted major pharmaceutical companies like Roche and Johnson & Johnson, along with hospitals.

The new funding will help it to expand its operations, deploy key AI models, and grow its network of biopharma clients.

Read also - Alstin Capital funding news – Munich-based Alstin Capital has Secured €175 Million in Funding

The Series A funding will also help it to host advanced models, like those used for protein-complex prediction, by accessing more training data that is currently locked in private repositories.

After the funding, it will focus on offering complete solutions for important life sciences tasks, where working together on model training can greatly improve performance. This will strengthen it's position as a secure option for life sciences data networks, backed by the cybersecurity expertise of its investors, OTB Ventures and eCAPITAL.

Lead investor OTB Ventures highlighted the potential of Apheris’ technology. Marcin Hejka Co-Founder and General Partner at OTB Ventures remarked: “We are thrilled to partner with Apheris as the lead investor in this equity round. It is pioneering the future of distributed data infrastructure enabling organizations to unlock the full potential of their AI/ML workloads while keeping sensitive raw data secure and local. By addressing the most pressing data challenges and allowing seamless, secure collaboration Apheris product is setting new standards for data-driven innovations. We are confident that Apheris’ exceptional team and cutting-edge technology will drive significant value and redefine the future of AI-powered decision-making.”

Similarly, eCAPITAL underscored the importance of secure data collaboration in healthcare. Hannes Schill Managing Partner at eCAPITAL noted: “We have closely followed Apheris’ journey since its inception and have been impressed by Apheris’ technological advancements in federated computing. As cybersecurity investors, we recognize the growing importance of secure and private data collaboration, particularly in the life sciences sector where such capabilities can drive transformative outcomes. Apheris enables organizations to unlock value out of their IP-sensitive data while maintaining full control over it. We are proud to support the Apheris team in scaling its technology and redefining secure data collaboration in healthcare and beyond.”

It's aims to create the largest secure life sciences data network by the end of 2025, positioning itself as a key player in the growing field of AI and data-driven healthcare solutions.

About Apheris

Apheris provides secure, private, and controlled access to data for machine learning and analytics. As models become more common, data is becoming the key differentiator for businesses. However, companies must protect their data and intellectual property while using it for machine learning.